Transcatheter (percutaneous) Mitral Valve Market: By Product Type (Transfemoral implantation, Transapical implantation), By Distribution Channel (Hospitals, Cardiac care centers, Others), and Geography (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa)  

Purchase Option

$ 4400
$ 6600
$ 8900

Transcatheter (percutaneous) Mitral Valve Market report gives a comprehensive outlook on butyric acid derivatives across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on gives historical, current, and future market sizes (US$ Mn) on the basis of product, animal feed and region. This report studies global transcatheter (percutaneous) mitral valve market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global butyric acid derivatives market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Transcatheter (percutaneous) mitral valve is used to treat mitral regurgitation (MR). Mitral valve disease is the second most common valvular heart disease in adults. MR is classified as either primary (degenerative) or secondary (functional). Primary MR from degenerative valve disease is due to a primary disruption of the mitral valve apparatus from either prolapsed or flail leaflets. Secondary MR on the other hand is due to remodeling of the left ventricle resulting inappropriate coaptation of the mitral leaflets. Trans catheter heart valve implantation procedure helps in replacing the heart valve with prosthetic valve for treatment of severe aortic stenosis and mitral regurgitation. This increases survival rate of patients and helps in reducing severe degenerative aortic stenosis.

Transcatheter Percutaneous Mitral Valve Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

X%

Largest Market

North America

Fastest Growing Market

N/A
Transcatheter (percutaneous) Mitral Valve Market Dynamics

Increase in the prevalence of cardiac disorders and increasing aging population are expected to drive the market. The increasing demand for less invasive procedure for high risk patients, severe aortic stenosis disorder and growing prevalence of mitral regurgitation are expected to drive the growth of Transcatheter (percutaneous) mitral valve market. Furthermore, conditions like speedy recovery, shorter span of time required for the patient to stay in the hospital are favoring the implantation of the transcatheter (percutaneous) mitral valve implantation. However, the high costs of the transcatheter heart valves, risk involved in the procedure such as improper positioning of the implant and device related issues such as product recalls by the manufacturers are expected to hamper the growth of transcatheter (percutaneous) mitral valve market.

Transcatheter Percutaneous Mitral Valve Market Segmentation

By Product Type
  • Transfemoral implantation
  • Transapical implantation
By Distribution Channel
  • Hospitals
  • Cardiac care centers
  • Others
By Geography
  • North America
  • Europe,
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Transcatheter Mitral Valve Market is expected to reach USD 3.2 Billion by 2029.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis
1.Executive Summary
2.Global Transcatheter (Percutaneous) Mitral Valve Market Introduction 
2.1.Global Transcatheter (Percutaneous) Mitral Valve Market  - Taxonomy
2.2.Global Transcatheter (Percutaneous) Mitral Valve Market  - Definitions
2.2.1.Product Type
2.2.2.Distribution Channel
2.2.3.Region
3.Global Transcatheter (Percutaneous) Mitral Valve Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Transcatheter (Percutaneous) Mitral Valve Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Transcatheter (Percutaneous) Mitral Valve Market  By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Transfemoral implantation
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Transapical implantation
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Transcatheter (Percutaneous) Mitral Valve Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cardiac care centers
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Transcatheter (Percutaneous) Mitral Valve Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Transcatheter (Percutaneous) Mitral Valve Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Transfemoral implantation
8.1.2.Transapical implantation
8.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Cardiac care centers
8.2.3.Others
8.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Transcatheter (Percutaneous) Mitral Valve Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Transfemoral implantation
9.1.2.Transapical implantation
9.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Cardiac care centers
9.2.3.Others
9.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
9.3.7.
10.Asia Pacific (APAC) Transcatheter (Percutaneous) Mitral Valve Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Transfemoral implantation
10.1.2.Transapical implantation
10.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Cardiac care centers
10.2.3.Others
10.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Transcatheter (Percutaneous) Mitral Valve Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Transfemoral implantation
11.1.2.Transapical implantation
11.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Cardiac care centers
11.2.3.Others
11.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Transcatheter (Percutaneous) Mitral Valve Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Transfemoral implantation
12.1.2.Transapical implantation
12.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Cardiac care centers
12.2.3.Others
12.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Boston Scientific Corporation (U.S)
13.2.2.Abbott Laboratories (U.S)
13.2.3.Edwards Lifesciences Corporation
13.2.4.Micro Interventional Devices (U.S)
13.2.5.Neochord Inc. (U.S)
13.2.6.Medtronic, Inc. (U.S)
13.2.7.Jude Medical, Inc. (U.S)
13.2.8.JenaValve Technology (U.S)
13.2.9.Livanova Plc, (U.K)
13.2.10.Colibri Heart Valve, Llc. (U.S)
13.2.11.Neovasc (Canada)
13.2.12.Biotronik SE & Co. KG (Germany)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Boston Scientific Corporation (U.S)
  • Abbott Laboratories (U.S)
  • Edwards Lifesciences Corporation
  • Micro Interventional Devices (U.S)
  • Neochord Inc. (U.S)
  • Medtronic, Inc. (U.S)
  • Jude Medical, Inc. (U.S)
  • JenaValve Technology (U.S)
  • Livanova Plc, (U.K)
  • Colibri Heart Valve, Llc. (U.S)
  • Neovasc (Canada)
  • Biotronik SE & Co. KG (Germany)

Adjacent Markets